CD73 Mouse Monoclonal Antibody [A6F9] (HA601011)

UNIPROT #

P21589

PROTEIN NAME

CD73

SYNONYMS

5' NT antibody;5' nucleotidase (CD73) antibody;5' nucleotidase precursor antibody;5' nucleotidase, ecto antibody;5' nucleotidase, ecto (CD73) antibody;5'-NT antibody;5'-nucleotidase antibody;5NTD_HUMAN antibody;CD73 antibody;CD73 antigen antibody;E5NT antibody;Ecto 5' nucleotidase antibody;Ecto-5'-nucleotidase antibody;eN antibody;eNT antibody;NT antibody;NT5 antibody;NT5E antibody;NTE antibody;Purine 5 Prime Nucleotidase antibody

SUBCELLULAR LOCATION

Cell membrane.

FUNCTION

5′-nucleotidase (5′-NT), also known as ecto-5′-nucleotidase or CD73 (cluster of differentiation 73), is an enzyme that in humans is encoded by the NT5E gene. CD73 commonly serves to convert AMP to adenosine. Ecto-5-prime-nucleotidase catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, the preferred substrate being AMP. The enzyme consists of a dimer of 2 identical 70-kD subunits bound by a glycosyl phosphatidyl inositol linkage to the external face of the plasma membrane. The enzyme is used as a marker of lymphocyte differentiation. Consequently, a deficiency of NT5 occurs in a variety of immunodeficiency diseases. Other forms of 5-prime nucleotidase exist in the cytoplasm and lysosomes and can be distinguished from ecto-NT5 by their substrate affinities, requirement for divalent magnesium ion, activation by ATP, and inhibition by inorganic phosphate. Rare allelic variants are associated with a syndrome of adult-onset calcification of joints and arteries (CALJA) affecting the iliac, femoral, and tibial arteries reducing circulation in the legs and the joints of the hands and feet causing pain. NT5E can act as an immune inhibitory control molecule. Free adenosine generated by NT5E inhibits cellular immune responses and thereby promotes immune escape of tumor cells.